REFERENCES
1. Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med. 2009;25:563-77.
2. Rodgers JL, Jones J, Bolleddu SI, et al. Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Dis. 2019;6:19.
3. Qu C, Liao S, Zhang J, et al. Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019. Eur Heart J Qual Care Clin Outcomes. 2024;10:143-53.
4. Gadó K, Szabo A, Markovics D, Virág A. Most common cardiovascular diseases of the elderly - A review article. Dev Health Sci. 2022;4:27-32.
5. Wu D, Jian C, Peng Q, et al. Prohibitin 2 deficiency impairs cardiac fatty acid oxidation and causes heart failure. Cell Death Dis. 2020;11:181.
6. Slawik M, Vidal-Puig AJ. Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev. 2006;5:144-64.
7. White PJ, McGarrah RW, Grimsrud PA, et al. The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase. Cell Metab. 2018;27:1281-93.e7.
8. Chen X, Kang R, Kroemer G, Tang D. Organelle-specific regulation of ferroptosis. Cell Death Differ. 2021;28:2843-56.
10. Sun Z, Wu Y, Ordog T, et al. Aberrant signature methylome by DNMT1 hot spot mutation in hereditary sensory and autonomic neuropathy 1E. Epigenetics. 2014;9:1184-93.
11. Wu Y, Chen J, Sun Y, et al. PGN and LTA from staphylococcus aureus induced inflammation and decreased lactation through regulating DNA methylation and histone H3 acetylation in bovine mammary epithelial cells. Toxins. 2020;12:238.
12. Fang WF, Chen YM, Lin CY, et al. Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression. J Inflamm. 2018;15:3.
14. Ghazi T, Nagiah S, Chuturgoon AA. Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells. Epigenetics. 2021;16:79-91.
15. Yang X, Gao Y, Ji Z, et al. Dual functional molecular imprinted polymer-modified organometal lead halide perovskite: synthesis and application for photoelectrochemical sensing of salicylic acid. Anal Chem. 2019;91:9356-60.
16. Yang H, Sun Y, Li Q, Jin F, Dai Y. Diverse epigenetic regulations of macrophages in atherosclerosis. Front Cardiovasc Med. 2022;9:868788.
17. Namba-Fukuyo H, Funata S, Matsusaka K, et al. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection. Oncotarget. 2016;7:81512-26.
18. Choi J, Diao H, Faliti CE, et al. Bcl-6 is the nexus transcription factor of T follicular helper cells via repressor-of-repressor circuits. Nat Immunol. 2020;21:777-89.
19. Paramasivam A, Priyadharsini JV. m6A RNA methylation in heart development, regeneration and disease. Hypertens Res. 2021;44:1236-7.
20. Piersanti RL, Santos JEP, Sheldon IM, Bromfield JJ. Lipopolysaccharide and tumor necrosis factor-alpha alter gene expression of oocytes and cumulus cells during bovine in vitro maturation. Mol Reprod Dev. 2019;86:1909-20.
21. Zeybel M, Hardy T, Wong YK, et al. Multigenerational epigenetic adaptation of the hepatic wound-healing response. Nat Med. 2012;18:1369-77.
22. Li R, Li X, Zhao J, et al. Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation. Theranostics. 2022;12:976-98.
23. Wang H, Zhong J, Zhang C, et al. The whole-transcriptome landscape of muscle and adipose tissues reveals the ceRNA regulation network related to intramuscular fat deposition in yak. BMC Genomics. 2020;21:347.
24. Liao CG, Liang XH, Ke Y, et al. Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis. Oncogene. 2022;41:1780-94.
25. Leung YT, Shi L, Maurer K, et al. Interferon regulatory factor 1 and histone H4 acetylation in systemic lupus erythematosus. Epigenetics. 2015;10:191-9.
26. Wang Z, Zhang Y, Zhu S, et al. A small molecular compound CC1007 induces cross-lineage differentiation by inhibiting HDAC7 expression and HDAC7/MEF2C interaction in BCR-ABL1(-) pre-B-ALL. Cell Death Dis. 2020;11:738.
27. Liu B, Ou WC, Fang L, Tian CW, Xiong Y. Myocyte enhancer factor 2A plays a central role in the regulatory networks of cellular physiopathology. Aging Dis. 2023;14:331-49.
28. Tobin SW, Hashemi S, Dadson K, et al. Heart failure and MEF2 Transcriptome dynamics in response to β-blockers. Sci Rep. 2017;7:4476.
29. Yu X, Zhang L, Wen G, et al. Upregulated sirtuin 1 by miRNA-34a is required for smooth muscle cell differentiation from pluripotent stem cells. Cell Death Differ. 2015;22:1170-80.
30. Wu S, Fatkhutdinov N, Fukumoto T, et al. SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cells. Nat Commun. 2018;9:4116.
31. Ronnebaum SM, Patterson C. The FoxO family in cardiac function and dysfunction. Annu Rev Physiol. 2010;72:81-94.
32. Koczor CA, Ludlow I, Fields E, et al. Mitochondrial polymerase gamma dysfunction and aging cause cardiac nuclear DNA methylation changes. Physiol Genomics. 2016;48:274-80.
33. Hoernle K, Abt DL, Fischer KM, et al. Arc-parallel flow in the mantle wedge beneath Costa Rica and Nicaragua. Nature. 2008;451:1094-7.
34. Tarragó MG, Chini CCS, Kanamori KS, et al. A potent and specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD+ decline. Cell Metab. 2018;27:1081-95.e10.
35. Paneni F, Diaz Cañestro C, Libby P, Lüscher TF, Camici GG. The aging cardiovascular system: understanding it at the cellular and clinical levels. J Am Coll Cardiol. 2017;69:1952-67.
36. Wei Z, Xia J, Li J, et al. SIRT1 promotes glucolipid metabolic conversion to facilitate tumor development in colorectal carcinoma. Int J Biol Sci. 2023;19:1925-40.
37. Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac energy metabolism in heart failure. Circ Res. 2021;128:1487-513.
38. Chun SK, Lee S, Flores-Toro J, et al. Loss of sirtuin 1 and mitofusin 2 contributes to enhanced ischemia/reperfusion injury in aged livers. Aging Cell. 2018;17:e12761.
39. Li X, Chen C, Zhan X, et al. R13 preserves motor performance in SOD1(G93A) mice by improving mitochondrial function. Theranostics. 2021;11:7294-307.
40. Chang Y, Sun L, Kokura K, et al. MPP8 mediates the interactions between DNA methyltransferase Dnmt3a and H3K9 methyltransferase GLP/G9a. Nat Commun. 2011;2:533.
41. Mohni KN, Wessel SR, Zhao R, et al. HMCES maintains genome integrity by shielding Abasic sites in single-strand DNA. Cell. 2019;176:144-53.e13.
42. Lesker TR, Durairaj AC, Gálvez EJC, et al. An integrated metagenome catalog reveals new insights into the murine gut microbiome. Cell Rep. 2020;30:2909-22.e6.
43. Delahaye F, Wijetunga NA, Heo HJ, et al. Sexual dimorphism in epigenomic responses of stem cells to extreme fetal growth. Nat Commun. 2014;5:5187.
44. Ghoneim HE, Fan Y, Moustaki A, et al. De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation. Cell. 2017;170:142-57.e19.
45. Zhang Q, Zhang Y, Sun S, et al. ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway. Cell Death Dis. 2021;12:15.
46. Pararasa C, Ikwuobe J, Shigdar S, et al. Age-associated changes in long-chain fatty acid profile during healthy aging promote pro-inflammatory monocyte polarization via PPARγ. Aging Cell. 2016;15:128-39.
47. Lim JH, Kang YJ, Lee BY, et al. Epigenome-wide base-resolution profiling of DNA methylation in chorionic villi of fetuses with Down syndrome by methyl-capture sequencing. Clin Epigenetics. 2019;11:180.
48. Mehta AP, Li H, Reed SA, Supekova L, Javahishvili T, Schultz PG. Replacement of 2'-Deoxycytidine by 2'-Deoxycytidine analogues IN THe E. coli genome. J Am Chem Soc. 2016;138:14230-3.
49. Hou X, Shi X, Zhang W, et al. LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma. Cell Death Dis. 2021;12:347.
50. Flores A, Sandoval-Gonzalez S, Takahashi R, et al. Increased lactate dehydrogenase activity is dispensable in squamous carcinoma cells of origin. Nat Commun. 2019;10:91.
51. Tan X, Ye J, Liu W, et al. Acrylamide aggravates cognitive deficits at night period via the gut-brain axis by reprogramming the brain circadian clock. Arch Toxicol. 2019;93:467-86.
52. Hudec M, Dankova P, Solc R, Bettazova N, Cerna M. Epigenetic regulation of circadian rhythm and its possible role in diabetes mellitus. Int J Mol Sci. 2020;21:3005.
53. Tatton-Brown K, Seal S, Ruark E, et al. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability. Nat Genet. 2014;46:385-8.
54. Bellet MM, Sassone-Corsi P. Mammalian circadian clock and metabolism - the epigenetic link. J Cell Sci. 2010;123:3837-48.
55. Kwapis JL, Alaghband Y, Kramár EA, et al. Epigenetic regulation of the circadian gene Per1 contributes to age-related changes in hippocampal memory. Nat Commun. 2018;9:3323.
56. Lamming DW, Ye L, Katajisto P, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012;335:1638-43.
57. Hardy T, Mann DA. Epigenetics in liver disease: from biology to therapeutics. Gut. 2016;65:1895-905.
58. Hattori M, Yokoyama Y, Hattori T, et al. Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts. Exp Dermatol. 2015;24:841-6.
59. Koh JH, Hancock CR, Terada S, Higashida K, Holloszy JO, Han DH. PPARβ is essential for maintaining normal levels of PGC-1α and mitochondria and for the increase in muscle mitochondria induced by exercise. Cell Metab. 2017;25:1176-85.e5.
60. Deng W, Wei X, Xie Z, et al. Inhibition of PLK3 attenuates tubular epithelial cell apoptosis after renal ischemia-reperfusion injury by blocking the ATM/P53-mediated DNA damage response. Oxid Med Cell Longev. 2022;2022:4201287.
61. Gao Q, Luo J, Pan J, et al. Integrative analyses identify HIF-1α as a potential protective role with immune cell infiltration in adamantinomatous craniopharyngioma. Front Immunol. 2022;13:949509.
62. Byrne NJ, Soni S, Takahara S, et al. Chronically elevating circulating ketones can reduce cardiac inflammation and blunt the development of heart failure. Circ Heart Fail. 2020;13:e006573.
63. Taylor MD, Sadhukhan S, Kottangada P, et al. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome. Sci Transl Med. 2010;2:37ra44.
64. Yang J, Wang B, Li N, Zhou Q, Zhou W, Zhan Z. Salvia miltiorrhiza and carthamus tinctorius extract prevents cardiac fibrosis and dysfunction after myocardial infarction by epigenetically inhibiting Smad3 expression. Evid Based Complement Alternat Med. 2019;2019:6479136.
65. Eichner LJ, Curtis SD, Brun SN, et al. HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer. Sci Adv. 2023;9:eadd3243.
66. Sullivan JM, Badimon A, Schaefer U, et al. Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice. J Exp Med. 2015;212:1771-81.
67. Stomper J, Niroula A, Belizaire R, McConkey M, Bandaru TS, Ebert BL. Sex differences in DNMT3A-mutant clonal hematopoiesis and the effects of estrogen. Cell Rep. 2025;44:115494.
68. Sano S, Oshima K, Wang Y, et al. Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1β/NLRP3 inflammasome. J Am Coll Cardiol. 2018;71:875-86.
69. Wang S, Hu S, Luo X, et al. Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction. EBioMedicine. 2022;78:103964.
70. Li X, Xiong X, Zhang M, et al. Base-resolution mapping reveals distinct m1A methylome in nuclear- and mitochondrial-encoded transcripts. Mol Cell. 2017;68:993-1005.e9.
71. Gokhale NS, McIntyre ABR, McFadden MJ, et al.
72. Zhao Z, Meng J, Su R, et al. Epitranscriptomics in liver disease: basic concepts and therapeutic potential. J Hepatol. 2020;73:664-79.
73. Wu C, Chen W, He J, et al. Interplay of m6A and H3K27 trimethylation restrains inflammation during bacterial infection. Sci Adv. 2020;6:eaba0647.
74. Berulava T, Buchholz E, Elerdashvili V, et al. Changes in m6A RNA methylation contribute to heart failure progression by modulating translation. Eur J Heart Fail. 2020;22:54-66.
75. Weems JC, Griesel BA, Olson AL. Class II histone deacetylases downregulate GLUT4 transcription in response to increased cAMP signaling in cultured adipocytes and fasting mice. Diabetes. 2012;61:1404-14.
76. Chen YG, Chen R, Ahmad S, et al. N6-Methyladenosine Modification Controls Circular RNA Immunity. Mol Cell. 2019;76:96-109.e9.
77. Van Haute L, Lee SY, McCann BJ, et al. NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs. Nucleic Acids Res. 2019;47:8720-33.
78. Cui L, Ma R, Cai J, et al. RNA modifications: importance in immune cell biology and related diseases. Signal Transduct Target Ther. 2022;7:334.
79. Chen H, Yang H, Zhu X, et al. m5C modification of mRNA serves a DNA damage code to promote homologous recombination. Nat Commun. 2020;11:2834.
80. Antonicka H, Choquet K, Lin ZY, Gingras AC, Kleinman CL, Shoubridge EA. A pseudouridine synthase module is essential for mitochondrial protein synthesis and cell viability. EMBO Rep. 2017;18:28-38.
81. Hermon SJ, Sennikova A, Becker S. Quantitative detection of pseudouridine in RNA by mass spectrometry. Sci Rep. 2024;14:27564.
82. Goh YT, Koh CWQ, Sim DY, Roca X, Goh WSS. METTL4 catalyzes m6Am methylation in U2 snRNA to regulate pre-mRNA splicing. Nucleic Acids Res. 2020;48:9250-61.
84. Zheng L, Chen X, He X, et al. METTL4-mediated mitochondrial DNA N6-methyldeoxyadenosine promoting macrophage inflammation and atherosclerosis. Circulation. 2025;151:946-65.
85. Li Y, Liu Y, Chen Z, et al. Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway. Biomed Pharmacother. 2023;160:114319.
86. Ohshiro T, Konno M, Asai A, et al. Single-molecule RNA sequencing for simultaneous detection of m6A and 5mC. Sci Rep. 2021;11:19304.
87. Shah P, Ding Y, Niemczyk M, Kudla G, Plotkin JB. Rate-limiting steps in yeast protein translation. Cell. 2013;153:1589-601.
88. Gan XT, Zhao G, Huang CX, Rowe AC, Purdham DM, Karmazyn M. Identification of fat mass and obesity associated (FTO) protein expression in cardiomyocytes: regulation by leptin and its contribution to leptin-induced hypertrophy. PLoS One. 2013;8:e74235.
89. Su R, Dong L, Li C, et al. R-2HG exhibits anti-tumor activity by targeting FTO/m6A/MYC/CEBPA signaling. Cell. 2018;172:90-105.e23.
90. Burghardt KJ, Goodrich JM, Dolinoy DC, Ellingrod VL. DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder. Epigenomics. 2015;7:343-52.
91. Pitt B, Kober L, Ponikowski P, et al. Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial. Eur Heart J. 2013;34:2453-63.
92. Saucedo R, Valencia J, Gutierrez C, et al. Gene variants in the FTO gene are associated with adiponectin and TNF-alpha levels in gestational diabetes mellitus. Diabetol Metab Syndr. 2017;9:32.
93. Gu C, Wang Z, Zhou N, et al. Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6-methyladenosine of Notch1. Mol Cancer. 2019;18:168.
94. Fang L, Wang W, Li G, et al. CIGAR-seq, a CRISPR/Cas-based method for unbiased screening of novel mRNA modification regulators. Mol Syst Biol. 2020;16:e10025.
95. Xu Z, Lv B, Qin Y, Zhang B. Emerging roles and mechanism of m6A methylation in cardiometabolic diseases. Cells. 2022;11:1101.
96. Liu C, Li C, Liu Y. The role of metabolic reprogramming in pancreatic cancer chemoresistance. Front Pharmacol. 2022;13:1108776.
97. Deng LJ, Deng WQ, Fan SR, et al. m6A modification: recent advances, anticancer targeted drug discovery and beyond. Mol Cancer. 2022;21:52.
98. Schwartz S, Bernstein DA, Mumbach MR, et al. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell. 2014;159:148-62.
99. Azubel M, Koivisto J, Malola S, et al. Nanoparticle imaging. Electron microscopy of gold nanoparticles at atomic resolution. Science. 2014;345:909-12.
100. Glazer AM, Davogustto G, Shaffer CM, et al. Arrhythmia variant associations and reclassifications in the eMERGE-III sequencing study. Circulation. 2022;145:877-91.
101. Jiang L, Wang X, Zhan X, et al. Advance in circular RNA modulation effects of heart failure. Gene. 2020;763:100036.
102. Chen LY, Wang L, Ren YX, et al. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation. Mol Cancer. 2020;19:164.
103. Mills RE, Walter K, Stewart C, et al. Mapping copy number variation by population-scale genome sequencing. Nature. 2011;470:59-65.
105. Guermah M, Palhan VB, Tackett AJ, Chait BT, Roeder RG. Synergistic functions of SII and p300 in productive activator-dependent transcription of chromatin templates. Cell. 2006;125:275-86.
106. Shi H, Wei J, He C. Where, When, and How: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74:640-50.
107. Zawistowski JS, Bevill SM, Goulet DR, et al. Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacologic targeting of the P-TEFb complex. Cancer Discov. 2017;7:302-21.
108. Fang F, Li G, Jing M, et al. C646 modulates inflammatory response and antibacterial activity of macrophage. Int Immunopharmacol. 2019;74:105736.
109. Ma F, Lei YY, Ding MG, Luo LH, Xie YC, Liu XL. LncRNA NEAT1 interacted with DNMT1 to regulate malignant phenotype of cancer cell and cytotoxic T cell infiltration via epigenetic inhibition of p53, cGAS, and STING in lung cancer. Front Genet. 2020;11:250.
110. Fierro C, Gatti V, La Banca V, et al. The long non-coding RNA NEAT1 is a ΔNp63 target gene modulating epidermal differentiation. Nat Commun. 2023;14:3795.
111. Hirose T, Yamazaki T, Nakagawa S. Molecular anatomy of the architectural NEAT1 noncoding RNA: the domains, interactors, and biogenesis pathway required to build phase-separated nuclear paraspeckles. Wiley Interdiscip Rev RNA. 2019;10:e1545.
112. Dukatz M, Dittrich M, Stahl E, et al. DNA methyltransferase DNMT3A forms interaction networks with the CpG site and flanking sequence elements for efficient methylation. J Biol Chem. 2022;298:102462.
113. Skeparnias I, Zhang J. Structural basis of NEAT1 lncRNA maturation and menRNA instability. Nat Struct Mol Biol. 2024;31:1650-4.
114. Jacq A, Becquet D, Guillen S, et al. Direct RNA-RNA interaction between Neat1 and RNA targets, as a mechanism for RNAs paraspeckle retention. RNA Biol. 2021;18:2016-27.
115. Yamazaki T, Souquere S, Chujo T, et al. Functional domains of NEAT1 architectural lncRNA induce paraspeckle assembly through phase separation. Mol Cell. 2018;70:1038-53.e7.
116. Chen ZX, Mann JR, Hsieh CL, Riggs AD, Chédin F. Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. J Cell Biochem. 2005;95:902-17.
117. Naveed A, Cooper JA, Li R, et al. NEAT1 polyA-modulating antisense oligonucleotides reveal opposing functions for both long non-coding RNA isoforms in neuroblastoma. Cell Mol Life Sci. 2021;78:2213-30.
118. Gu T, Lin X, Cullen SM, et al. DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells. Genome Biol. 2018;19:88.
119. Dong P, Xiong Y, Yue J, et al. Long non-coding RNA NEAT1: a novel target for diagnosis and therapy in human tumors. Front Genet. 2018;9:471.
120. Jiang L, Shao C, Wu QJ, et al. NEAT1 scaffolds RNA-binding proteins and the Microprocessor to globally enhance pri-miRNA processing. Nat Struct Mol Biol. 2017;24:816-24.
121. Kotini AG, Mpakali A, Agalioti T. Dnmt3a1 upregulates transcription of distinct genes and targets chromosomal gene clusters for epigenetic silencing in mouse embryonic stem cells. Mol Cell Biol. 2011;31:1577-92.
122. Wang Z, Fan P, Zhao Y, et al. NEAT1 modulates herpes simplex virus-1 replication by regulating viral gene transcription. Cell Mol Life Sci. 2017;74:1117-31.
123. Smith AM, LaValle TA, Shinawi M, et al. Functional and epigenetic phenotypes of humans and mice with DNMT3A overgrowth syndrome. Nat Commun. 2021;12:4549.
124. Bosselut R. Control of intra-thymic αβ T cell selection and maturation by H3K27 methylation and demethylation. Front Immunol. 2019;10:688.
125. Bayliak M, Burdyliuk N, Lushchak V. Growth on alpha-ketoglutarate increases oxidative stress resistance in the yeast saccharomyces cerevisiae. Int J Microbiol. 2017;2017:5792192.
126. Lin AP, Abbas S, Kim SW, et al. D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2. Nat Commun. 2015;6:7768.
127. Xu C, Wang L, Fozouni P, et al. SIRT1 is downregulated by autophagy in senescence and ageing. Nat Cell Biol. 2020;22:1170-9.
128. Wangpaichitr M, Wu C, Li YY, et al. Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer. Oncotarget. 2017;8:49275-92.
129. Afanas'ev I. New nucleophilic mechanisms of ros-dependent epigenetic modifications: comparison of aging and cancer. Aging Dis. 2014;5:52-62.
130. Chatterjee S, Daenthanasanmak A, Chakraborty P, et al. CD38-NAD+Axis regulates immunotherapeutic anti-tumor T cell response. Cell Metab. 2018;27:85-100.e8.
131. Jiménez-Loygorri JI, Villarejo-Zori B, Viedma-Poyatos Á, et al. Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during aging. Nat Commun. 2024;15:830.
132. Liu J, Zhang C, Hu W, Feng Z. Parkinson's disease-associated protein Parkin: an unusual player in cancer. Cancer Commun. 2018;38:40.
133. Jiang X, Liu B, Nie Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.
134. Harbauer AB, Hees JT, Wanderoy S, et al. Neuronal mitochondria transport Pink1 mRNA via synaptojanin 2 to support local mitophagy. Neuron. 2022;110:1516-31.e9.
135. Agirre X, Román-Gómez J, Vázquez I, et al. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. Int J Cancer. 2006;118:1945-53.
136. Kietzmann T, Petry A, Shvetsova A, Gerhold JM, Görlach A. The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system. Br J Pharmacol. 2017;174:1533-54.
137. Lee Y, Choe J, Park OH, Kim YK. Molecular mechanisms driving mRNA degradation by m6A modification. Trends Genet. 2020;36:177-88.
138. Sun Y, Shen W, Hu S, et al. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy. J Exp Clin Cancer Res. 2023;42:65.
139. Wang X, Lu Z, Gomez A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117-20.
140. Dorn LE, Lasman L, Chen J, et al. The N6-methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy. Circulation. 2019;139:533-45.
141. Kmietczyk V, Riechert E, Kalinski L, et al. m6A-mRNA methylation regulates cardiac gene expression and cellular growth. Life Sci Alliance. 2019;2:e201800233.
142. Mathiyalagan P, Adamiak M, Mayourian J, et al. FTO-dependent N6-methyladenosine regulates cardiac function during remodeling and repair. Circulation. 2019;139:518-32.
143. Donato E, Croci O, Sabò A, et al. Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors. Leukemia. 2017;31:479-90.
144. Mu J, Zhang D, Tian Y, Xie Z, Zou MH. BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1/Parkin-mediated mitophagy in vivo. J Mol Cell Cardiol. 2020;149:1-14.
145. Wang JY, Chen LJ, Qiang P. The potential role of N6-methyladenosine (m6A) demethylase fat mass and obesity-associated gene (FTO) in human cancers. Onco Targets Ther. 2020;13:12845-56.
146. Elkashef SM, Lin AP, Myers J, et al. IDH mutation, competitive inhibition of FTO, and RNA methylation. Cancer Cell. 2017;31:619-20.
147. Shaaban Z, Khoradmehr A, Amiri-Yekta A, Jafarzadeh Shirazi MR, Tamadon A. Pathophysiologic mechanisms of obesity- and chronic inflammation-related genes in etiology of polycystic ovary syndrome. Iran J Basic Med Sci. 2019;22:1378-86.
148. Kanemaru K, Cranley J, Muraro D, et al. Spatially resolved multiomics of human cardiac niches. Nature. 2023;619:801-10.
149. Riahi R, Wang S, Long M, et al. Mapping photothermally induced gene expression in living cells and tissues by nanorod-locked nucleic acid complexes. ACS Nano. 2014;8:3597-605.
150. Kuppe C, Ramirez Flores RO, Li Z, et al. Spatial multi-omic map of human myocardial infarction. Nature. 2022;608:766-77.
151. Yamada S, Ko T, Hatsuse S, et al. Spatiotemporal transcriptome analysis reveals critical roles for mechano-sensing genes at the border zone in remodeling after myocardial infarction. Nat Cardiovasc Res. 2022;1:1072-83.
152. Longenecker JZ, Gilbert CJ, Golubeva VA, Martens CR, Accornero F. Epitranscriptomics in the heart: a focus on m6A. Curr Heart Fail Rep. 2020;17:205-12.
153. Lee AC, Lee Y, Choi A, et al. Spatial epitranscriptomics reveals A-to-I editome specific to cancer stem cell microniches. Nat Commun. 2022;13:2540.
154. Palmer JA, Rosenthal N, Teichmann SA, Litvinukova M. Revisiting cardiac biology in the era of single cell and spatial omics. Circ Res. 2024;134:1681-702.
155. Duan Q, McMahon S, Anand P, et al. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure. Sci Transl Med. 2017;9:eaah5084.
156. Mills RJ, Humphrey SJ, Fortuna PRJ, et al. BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection. Cell. 2021;184:2167-82.e22.
157. Abdellatif M, Sedej S, Kroemer G. NAD+ metabolism in cardiac health, aging, and disease. Circulation. 2021;144:1795-817.
158. Lauritzen KH, Olsen MB, Ahmed MS, et al. Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication. Elife. 2021;10:e59828.
159. Lu TM, Tsai JY, Chen YC, et al. Downregulation of Sirt1 as aging change in advanced heart failure. J Biomed Sci. 2014;21:57.
160. Costantino S, Mengozzi A, Velagapudi S, et al. Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy. Cardiovasc Diabetol. 2023;22:312.
